Anzeige
Mehr »
Mittwoch, 22.07.2026 - Börsentäglich über 12.000 News
Aktie im Fokus: Gelingt jetzt der Turnaround?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
26.06.Enzene Premieres Nex Partnership Program at BIO 2026
25.06.Merck KGaA to Acquire Bio-Techne for $11.3B
25.06.DDL Appoints Jennifer Riter as Vice President of Analytical Testing Services
25.06.Agilent Completes Acquisition of Biocare Medical
25.06.Shilpa Biologicals Commissions Integrated ADC Drug Substance GMP Manufacturing Facilities
24.06.SK pharmteco Launches SKyvec Proprietary Multimodal Viral Vector Platform
24.06.Julie Kim Takes Helm as Takeda CEO
24.06.Circio, Tcelltech Enter CAR-T Cell Therapy Research Collaboration
24.06.Abbisko Therapeutics, Lilly Expand R&D Alliance
24.06.Combotope Therapeutics, Boehringer Ingelheim Partner on Tumor-Selective Antibodies for Cancer
23.06.TELEO Capital Acquires Applied Materials' Pharmaceutical Manufacturing Intelligence Platform
23.06.Sartorius, LFB Biomanufacturing Expand Collaboration
22.06.Parexel Launches Parexel Biotech Incubator
22.06.BioArctic, Lilly Ink Research Alliance
22.06.ICON Selects Microsoft to Power AI-enabled Clinical Development
22.06.AdvanCell Establishes U.S. Global HQ and Manufacturing Facility in Greater Boston
22.06.Lonza, InduPro Enter Licensing Agreement for Next-Gen ADCs
19.06.CenExel Taps Bethany Sensenig as New Chief Financial Officer
19.06.Neurizon, Elanco Ink Long-Term Supply Agreement for Human Health Monepantel
19.06.SK Pharmteco Partners with OTXL to Tackle Rare Diseases
19.06.PHCNA Launches CO2 Incubator Line for Cell-Culture Labs
19.06.ProChem Acquires Evonik Pharma Production Assets
18.06.Gandeeva, Zymeworks Using Cryo-EM to Enhance Antibody Drug Discovery
18.06.Nortiva Bio Launches, Developing Long-Acting Oral Medicines Via Proprietary Platform
18.06.Merck's Capvaxive Approved by FDA for Additional Indication in Pediatric Pneumococcal Disease